司替戊醇
 | |
| 臨床資料 | |
|---|---|
| 讀音 | stir"i pen' tol |
| 商品名 | Diacomit |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a618069 |
| 核准狀況 |
|
| 懷孕分級 |
|
| 給藥途徑 | By mouth |
| ATC碼 | |
| 法律規範狀態 | |
| 法律規範 |
|
| 識別資訊 | |
| |
| CAS號 | 137767-55-6  |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.051.329 |
| 化學資訊 | |
| 化學式 | C14H18O3 |
| 摩爾質量 | 234.30 g·mol−1 |
| 3D模型（JSmol） | |
| |
| |
司替戊醇（英語：Stiripentol，商品名Diacomit）是一種抗驚厥藥，用於治療嬰兒嚴重肌陣攣性癲癇（又稱Dravet綜合症）[3][4]。
參考文獻
[編輯]- ^ Diacomit 250mg hard capsules - Summary of Product Characteristics (SmPC). (emc). 31 May 2019 [8 November 2020]. （原始內容存檔於2020-11-13）.
- ^ Diacomit- stiripentol capsule Diacomit- stiripentol powder, for suspension. DailyMed. 15 May 2020 [8 November 2020]. （原始內容存檔於2020-08-06）.
- ^ 3.0 3.1 Diacomit EPAR. European Medicines Agency. [8 November 2020]. （原始內容存檔於2020-11-12）. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
- ^ Stiripentol Monograph for Professionals. Drugs.com. 31 August 2020 [8 November 2020]. （原始內容存檔於2020-10-11）.